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INTRODUCTION
Corneal transparency is a major prerequisite for normal vision. The corneal endothelium, which is comprised of a single layer of cells of neural crest origin, maintains the osmotic homeostasis of the cornea and is essential for ensuring corneal clarity. 1 Therefore, a healthy endothelium is essential. Unlike in other mammalian species, the capacity of the human corneal endothelium for regeneration after injury is severely limited. 2 3 In general, wound repair and cell loss are achieved by the enlargement and migration of the surrounding cells. 2 3 The normal endothelial cell count is about 3000 cells/mm 2 in young adults and decreases to approximately 2000 cells/mm 2 during the lifetime. 4 Although there is no exact threshold, a cell density less than 400e800 cells/mm 2 often produces corneal opacity through inadequate corneal hydration. 1 Corneal opacities due to endothelial cell loss are commonly irreversible. In such cases, keratoplasty is often the only therapeutic option to improve vision. 5 One major quality criterion for donor corneas for transplantation is the endothelial cell count and the success of corneal transplantation depends at least in part on a healthy endothelium in the donor cornea. 5 It has been demonstrated that the deterioration of the corneal endothelium in donor corneas for transplantation occurs more frequently with increasing length of organ culture time and leads to cell loss. 6 7 This results in an increased susceptibility of cells.
Reactive oxygen species (ROS) intermediates and oxidative stress are thought to induce apoptotic cell death and have been implicated in the progression of ageing. 8 Among various causes, oxidant species and oxidative stress are considered to be cytotoxic, and it has been suggested that they are responsible for corneal cell death. 9 There is evidence that the loss of endothelial cells is at least partly due to apoptosis. 10 Apart from this, many models have shown that apoptotic cell death is a result of changes in environmental stimuli, such as growth factors. The transforming growth factor beta (TGF-b) family includes three multifunctional proteins, TGF-b1, TGF-b2 and TGF-b3, that are found in aqueous humour. 11 TGF-b is involved in regulating cell differentiation, cell proliferation and other cell functions. 12 Altered levels of TGF-b have been reported in several ocular conditions and pathologies such as uveitis, glaucoma or diabetes, and are considered to be pro-apoptotic.
11 13e15 In addition, it has been demonstrated that the activity of TGF-b is related to the production of hydrogen peroxide (H 2 O 2 ) and induces oxidative stress in lens epithelial cells. 16 TGF-b2, the isoform of TGF-b most strongly expressed in human eyes, reportedly inhibits the proliferation of corneal endothelial cells. 17 18 Furthermore, TGF-b2 stimulates prostaglandin synthesis in corneal endothelium and inhibits its proliferation in a dose-dependent manner.
has proven its safety and its beneficial antimicrobial and antiinflammatory actions for many years. 19 In addition, minocycline has recently been demonstrated to have cytoprotective properties in several cellular systems, and in models for neurodegenerative and retinal disease. 20e23 The present study evaluated whether minocycline at various concentrations has toxic effects on cultivated human corneal endothelial cells (CECs). In addition, we investigated the effects of minocycline on viability, induction of cellular death and apoptosis in CECs. To elucidate the potential protective and anti-apoptotic effects of minocycline, the expression of two anti-apoptotic proteins, B-cell CLL/lymphoma 2 (Bcl-2) and X-linked inhibitor of apoptosis (XIAP) and their mRNA were quantified.
METHODS
Minocycline was obtained as lyophilised powder (Sigma-Aldrich, St Louis, Missouri, USA) and reconstituted with sterile water to obtain a 1 mM stock solution. This stock solution was then further diluted in a 1:1 mixture of M199/F12 medium (M199/ F12; Biochrom, Cambridge, UK) to obtain the final concentrations of 1, 5, 7.5, 10, 15, 20, 40, 50, 75, 100 and 150 mM.
Human corneal endothelial cells
Immortalised, cultured human CECs from a well established cell line (HCEC-SV40) were provided by Professor J Bednarz (University of Hamburg, Klinikum Eppendorf, Hamburg, Germany). 24 CECs were grown in a 1:1 mixture of M199/F12 medium (Biochrom, Cambridge, UK) supplemented with 5% fetal calf serum and without addition of antibiotics.
Cell culture treatment
For all cell culture experiments, CECs (2310 5 cells/well) were seeded in 35-mm diameter tissue culture dishes and exposed to minocycline concentrations (1e150 mM). For exposure to the various concentrations of minocycline, the CECs were kept for 24 h in serum-free conditions. After the cells were washed with phosphate buffered saline (PBS), they were incubated for 24 h with various concentrations of minocycline dissolved in a 1:1 mixture of M199/F12 medium for CECs. Then the serum-free medium containing minocycline was removed by carefully rinsing the cells with serum-free medium three times. After another 24 h of incubation with serum-free medium, cell viability assay, RNA isolation or protein extraction was performed.
For testing the various concentrations of minocycline under conditions of oxidative stress, the cells were treated for 24 h with the two tested concentrations of minocycline (15 and 20 mM), and then 200 mM H 2 O 2 was added for 4 h.
In unpublished pilot work in our laboratory several concentrations of H 2 O 2 and different treatment times were tested. The concentration of 200 mM H 2 O 2 and a 4-h treatment was chosen in order to produce an adequate degree of cell injury in untreated CECs.
The serum-free medium containing H 2 O 2 and minocycline was then removed by carefully rinsing the cells with serum-free medium three times. After another 24 h of incubation with serum-free medium, cell viability assay, RNA isolation or protein extraction was performed.
For testing minocycline in the presence of TGF-b2, cells were treated for 24 h with the various concentrations of minocycline (15 and 20 mM) and then 1 ng/ml TGF-b2 was added. After another 24 h of incubation with minocycline and TGF-b2, RNA isolation or protein extraction was performed.
MTT assay
Tetrazolium dye-reduction assay (MTT; 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) was used to determine the cell survival rate. The MTTassay was performed as described in the literature by Mosmann 25 
Liveedead cell viability assay
Confluent CECs were prepared and treated as described above. Cell viability was quantified based on a two-colour fluorescence assay. The nuclei of non-viable cells appear red because of staining by the membrane-impermeable dye propidium iodide (Sigma-Aldrich), whereas the nuclei of all cells were stained with the membrane-permeable dye Hoechst 33342 (Intergen; Purchase, New York, USA). Confluent cultures of CECs growing on coverslips in 35-mm tissue culture dishes were exposed to the various concentrations of minocycline as described for the MTT assay. For the evaluation of cell viability, the cells were washed in PBS and incubated with 2.0 mg/ml propidium iodide and 1.0 mg/ml Hoechst 33342 for 20 min at 378C. Subsequently, the cells were analysed with an epifluorescence microscope (Aristoplan; Leitz, Wetzlar, Germany). The labelled nuclei were then counted in fluorescence photomicrographs, and dead cells were expressed as a percentage of the total nuclei in the field. Data (mean6SD) are based on the sampling of six to 10 photomicrographs per condition in three independent experiments performed in duplicate. The percentage of dead cells was scored by counting at least 500 cells in fluorescence photomicrographs of representative fields. CECs of the same passage served as the control.
Detection of apoptosis
Apoptosis is characterised by membrane blebbing, condensation of cytoplasm and the activation of endogenous endonucleoses. This leads to internucleosomal cleavage of DNA and the generation of mono-and oligonucleosomes, which are tightly complexed with histones. To quantify apoptosis in CECs, quantitative detection of histone-associated DNA fragments in mono-and oligonucleosomes, a marker for apoptosis, was performed by an ELISA. CECs were treated with minocycline and 200 mM H 2 O 2 or TGF-b2 as described before. Cells were then collected from culture dishes and subjected to a cell death detection ELISA (Roche Applied Science, Indianapolis, Indiana, USA).
RNA isolation and real-time PCR
The total RNA for Bcl-2 and XIAP detection was isolated from 35-mm tissue culture dishes by the guanidium thiocyanateephenolechloroform extraction method. Quantification of Bcl-2 and XIAP mRNA was performed by reverse transcriptase (RT)-PCR using a LightCycler Instrument (LightCycler System, Roche Diagnostics, Germany) according to previous descriptions. 26 The levels of Bcl-2 and XIAP mRNA were determined as a relative ratio (RR), which was calculated by dividing the level of Bcl-2 and XIAP mRNA by the level of the 18S rRNA housekeeping gene in the same samples. All experiments were performed at least in triplicate and repeated three times. The primers used for RT-PCR are shown in table 1.
Protein extraction and western blot analysis of Bcl-2 and XIAP
CECs grown on 35-mm tissue culture dishes were washed twice with ice-cold PBS, collected, and lysed in RIPA cell lysis buffer. After centrifugation for 30 min at 19 000 g in a microfuge (5810R; Eppendorf, Hamburg, Germany) in the cold, the supernatant fraction was transferred to fresh tubes and stored at À708C for future use. The protein content was measured by the bicinchoninic acid (BCA) protein assay (Pierce, Rockford, Illinois, USA). Denatured proteins (1.2 mg) were separated under reducing conditions by electrophoresis using a 5% SDSepolyacrylamide stacking gel and a 12% SDSepolyacrylamide separating gel, transferred with semi-dry blotting onto a polyvinyl difluoride membrane (Roche Diagnostics), and probed with a mouse anti-Bcl-2-antibody or a mouse anti-XIAP-antibody as described previously. 26 Chemiluminescence was detected with an imager (LAS-1000; RayTest, Straubenhardt, Germany) and generated light units (LU). The exposure times ranged between 1 and 10 min. All experiments were performed at least in triplicate. Quantification of the chemiluminescence signal by densitometry was performed by using a specific computer software (AIDA; RayTest).
Statistical evaluation and expression of results
All data were analysed using SPSS 17.0 for Windows (SPSS Inc., Chicago, Illinois, USA). For all statistical tests, p<0.05 was considered significant. Results of the MTT assay are presented as mean (6SD) units of absorbance. Ten individual samples per group were measured in triplicate. Results of the RT-PCR are presented as mean (6SD) ratios of the investigated mRNA and 18S rRNA; all experiments were performed in triplicate and repeated three times. Western blot analysis was performed analogously; CEC culture experiments were performed at least in triplicate. Analysis of variance with Bonferroni correction in post hoc testing was applied to investigate statistical significance of differences. To evaluate the effects of treatment with the various concentrations of minocycline univariate ANOVA modelling was performed, considering the factors TGF-b treatment and H 2 O 2 concentration. Post hoc testing for significant factors applied Bonferroni correction.
RESULTS

Testing concentrations of minocycline in cultured CECs
No gross abnormalities could be detected in CECs with phasecontrast microscopy for minocycline concentrations up to 75 mM that had no minocycline pre-treatment showed pronounced morphological signs of toxicity such as abnormal shape and appearance, cellular lysis and destruction (data not shown).
MTT assay
Minocycline concentrations between 1 and 50 mM showed no significant toxic effects on CECs (24 h exposure). No significant decrease in cellular viability was detected compared with the control. Concentrations of minocycline between 75 mM (p¼0.696) and 100 mM (p#0.001) led to a dose-dependent reduction of viability. The concentration of minocycline that inhibited viability by 50% (IC 50 ) was determined from the doseeresponse curves and for 24-h application was approximately 100 mM (66. 
Liveedead assay for corneal endothelial cells
Detection of apoptosis
Expression of Bcl-2 and XIAP mRNA in CECs
Bcl-2 and XIAP mRNA expression was detected in every sample. All detected mRNA levels of Bcl-2 and XIAP were normalised to those of 18S rRNA, and values are expressed as the relative ratio (RR) of Bcl-2/18S or XIAP/18S. The findings indicate that treatment with minocycline leads to an increased mRNA expression of both Bcl-2 and XIAP. In contrast, TGF-b2 and H 2 O 2 treatment significantly decreased mRNA expression of Bcl-2 and XIAP in CECs. The cells treated with both minocycline and with TGF-b2 or H 2 O 2 seemed to compensate for the decrease of Bcl-2 and XIAP mRNA expression by TGF-b2 and H 2 O 2 reaching mRNA levels of Bcl-2 and XIAP comparable to those of the untreated controls or even higher. In addition, the cells pre-treated with minocycline showed significantly higher levels of Bcl-2 and XIAP mRNA in CECs than cells treated with TGF-b2 or H 2 O 2 only (figure 4).
Protein expression of Bcl-2 and XIAP in human CECs
To verify that the decrease in Bcl-2 and XIAP under TGF-b2 and H 2 O 2 treatment and the minocycline-induced increase in Bcl-2 and XIAP in mRNA transcription translates into increased protein synthesis, whole cellular protein extracts whole cellular 
DISCUSSION
Deterioration of the corneal endothelium can lead to endothelial cell loss and irreversible opacification of the cornea. Such loss is serious in humans as the capacity of corneal endothelial cell regeneration is limited. 2 3 Therefore, one major prerequisite for corneal clarity is the endothelial cell count.
Apoptosis is an important mechanism of corneal endothelial cell loss, both in physiological and pathological conditions. 10 In vitro investigations of bovine corneal endothelial cells have demonstrated that endothelial cell apoptosis is mediated by oxidative stress and that apoptosis is dependent on local environmental factors. 27 28 The aim of our study was to elucidate whether the tetracycline antibiotic minocycline offers properties to prevent apoptotic cell death and consecutive CEC loss in a cultured human corneal endothelial cell line in vitro. The cell line investigated does not only offer the morphological characteristics of the physiological corneal endothelium in vivo, but also possesses functional properties, such as the capacity to regulate stromal hydration. 29 The data presented might be useful in the prevention of endothelial cell loss of cultured donor corneas for transplantation and under certain conditions in vivo.
Minocycline is a well established and safe drug and has proven its antimicrobial and anti-inflammatory qualities for many years. 19 In addition to its antibiotic and anti-inflammatory activity, it has been shown to have cytoprotective characteristics against various stimuli, including oxidative stress, ischaemia and cytokines. 22 30e32 The cytoprotective effects of minocycline have been suggested to be anti-inflammatory and also antiapoptotic. Recent reports have demonstrated minocycline's antioxidant properties and its influence on caspases and nitric oxide synthase activity. 33 Its inhibiting effect on the release of apoptotic proteins, such as cytochrome c and Smac/Diabolo, and its induction of anti-apoptotic proteins, such as Bcl-2 or XIAP, have been described in several cellular systems. 20 22 Our results demonstrate that minocycline protects cultured corneal endothelial cells from oxidative stress. We were able to show that oxidative stress due to H 2 O 2 leads to an increase of cell death and apoptosis in the investigated human CEC line. This induction of apoptotic cell death went along with a decrease of two anti-apoptotic proteinsdBcl-2 and XIAP. In contrast, we were able to show that minocycline is able to attenuate this induction of cell death and that at least one cytoprotective mechanism of minocycline is its induction of these anti-apoptotic proteins (Bcl-2 and XIAP).
Bcl-2 is generally considered to be a custodian of mitochondrial functional integrity as it stabilises the mitochondrial membrane against the release of cytochrome c. Through its inhibitory effect on caspase activation, Bcl-2 is able to interrupt apoptosis. 34 It has been shown that Bcl-2 mediates cell survival and decreases apoptosis in human retinal pigment epithelial cells (RPE) 35 and other ocular and non-ocular cell lines. 36 37 XIAP is another potent and well-characterised anti-apoptotic protein. It is related to the tumour suppressor protein p35, which suppresses the activity of the apoptosis-promoting key caspases 3, 7 and 9. 38 It has been demonstrated that the overexpression of XIAP protects injured neuronal cells and photoreceptors from further compromise in vivo. 39 40 The growth factor TGF-b is expressed by almost every cell. Altered levels of TGF-b are associated with several ocular pathologies, including glaucoma.
14 It has been demonstrated that both acute and chronic glaucoma can lead to endothelial cell loss and that preoperative glaucoma is a major risk factor for increased endothelial cell loss following keratoplasty. 41 42 So another important finding of our investigations is that TGF-b2, the isoform of TGF-b most expressed in human eyes, induced apoptotic cell death in human CECs. This corresponds well to the apoptotic effects of TGF-b described previously in many cellular systems.
14 This induction of apoptosis was accompanied by a reduction of Bcl-2 and XIAP levels in CECs. In contrast, we were able to show that minocycline increases Bcl-2 and XIAP expression on both the RNA level and the protein level, not only under standard conditions but also under conditions of oxidative stress and increased levels of TGF-b2.
Because of its antibiotic and anti-inflammatory actions, minocycline is widely used and has proven its safety as an oral antibiotic for many years. 19 43 In our in vitro study, treatment of CEC with minocycline in concentrations up to 50 mM under standard conditions did not reveal significant toxicity. However, after treatment with H 2 O 2 , doses >40 mM led to a significant decrease in the viability of cells. In our experimental setting minocycline concentrations of 20 mM revealed anti-apoptotic effects. This would correspond to an estimated dose of approximately 750 mg/day in human adults, which is undoubtedly a high dosage. 19 44 45 On the other hand, previous reports have shown that daily tetracyclin doses >2000 mg are still relatively safe in healthy pregnant women 19 Our results from cell culture experiments seem to indicate that minocycline protects the corneal endothelium from two potential apoptotic stimuli. In addition, minocycline increases the expression of two anti-apoptotic proteins in cultured CECs. Even if the therapeutic range of minocycline in our setting was limited, it might be worthwhile to further investigate minocycline's anti-apoptotic and cyto-protective effects on the corneal endothelium.
The CECs we used for our experiments have demonstrated morphological characteristics of the physiological corneal endothelium in vivo, but also possess functional properties, such as the capacity to regulate stromal hydration. 29 Nevertheless, one major limitation of our study might be that the cells we used for our experiments were from an immortalised, cultured cell line with all its limitations, and our results cannot be directly transferred in vivo. In addition, it is not clear that the cytoprotective effect of minocycline seen after short-term exposure also occurs after long-term exposure.
Nevertheless, our findings indicate that minocycline might offer cytoprotective properties that could help to increase corneal endothelial cell survival and resistance to stress as it occurs under certain pathological conditions and ocular disease. 9 The antiapoptotic, cytoprotective effects of minocycline described here may provide a basis for the prevention of corneal endothelial cell loss under pathological conditions and help to make these cells less susceptible to cellular stress. Indeed, further investigations are necessary to corroborate this data, but our in vitro findings suggest that minocycline might offer properties that could potentially prevent corneal endothelial cell loss in vivo.
